The United States Department of Justice has determined that the medical school of the University of California, Los Angeles illegally used race as a factor in admissions, the Guardian reported on Tuesday. The finding, the most consequential federal civil-rights enforcement action against a major American medical school in years, follows the 2023 Supreme Court ruling in Students for Fair Admissions v. Harvard that ended race-conscious admissions at private and public universities receiving federal funds. UCLA’s medical school is consistently among the most selective in the country; the finding will trigger a federal compliance process whose contours are still being defined and which is likely to be replicated at peer institutions. The action is also one of several this week that have signalled an unusually active stance by the Civil Rights Division, including the cancellation of US tourist visas for board members of a Costa Rican newspaper critical of a Trump ally — a different kind of action, but indicative of an administration willing to use civil-rights and immigration tools assertively.
The received wisdom
The progressive reading of the UCLA finding is that it represents the predictable continuation of a politically motivated rollback of decades of carefully constructed diversity programmes. On this view, the SFFA decision was wrong; its enforcement at UCLA is worse; and the practical consequence will be a sharp reduction in the number of Black, Hispanic and Native American students entering the medical pipeline at one of the country’s largest training hospitals, with downstream effects on health outcomes in the communities those graduates would have served. The argument, made earnestly and not without evidence, is that medicine is a field in which patient trust and demographic familiarity matter, and that an admissions system blind to race in the literal sense will produce a workforce demographically less representative of the country it serves. That, the critique runs, is a public-health failure dressed up as a constitutional victory. The corollary is that the DOJ’s other recent enforcement actions, including those targeting universities and foreign newspapers, fit a pattern of executive overreach.
A different read
The honest case for the SFFA ruling, and for its enforcement at UCLA, is one its critics rarely engage. It begins from a recognition that the post-1978 Bakke compromise — under which racial preferences were permitted as one factor among many, indefinitely, on the theory that diversity was a compelling state interest — was always going to end in litigation, because it depended on a fiction that universities could not honestly maintain. The fiction was that race was a “factor” in some abstract sense rather than the dispositive variable in the cases where it operated. The discovery process in SFFA v. Harvard, and the parallel cases at the University of North Carolina, produced documentary evidence that this distinction had collapsed in practice. The Court did not invent a constitutional rule; it noticed that an existing one had been drained of meaning.
The UCLA finding is therefore not the beginning of a new ideological campaign. It is the slow operationalisation of a constitutional change that the universities themselves invited by failing to comply with the doctrine they were pretending to follow. The historical parallel is not the dismantling of affirmative action in California in 1996 — though that, the Proposition 209 episode, is instructive — but the long enforcement tail of Brown v. Board of Education. The 1954 ruling did not desegregate schools; the slow, unglamorous, court-by-court enforcement that followed for the next two decades did. SFFA is at the start of a similar process, and the medical schools are the natural locus, because medical admissions are unusually documented and unusually high-stakes.
There is a more subtle conservative point worth making. The progressive case for race-conscious admissions has always trafficked in two arguments at once: a reparative argument (about historical injustice) and a representational argument (about workforce demographics). These are not the same. The Court rejected only the second as a constitutional matter, and even there left intact a narrower path: admissions essays that invite applicants to discuss the role of race in their own life and how it has shaped them. The UCLA finding will turn on whether the school operated within that path or, as the DOJ’s investigators apparently concluded, used race as an unstated dispositive factor while gesturing toward holistic review. The legal point is narrow. The cultural point is wider.
The cultural point is that universities, and especially graduate-professional schools, were entrusted with the management of a delicate compromise and abused that trust. They told the country that race-conscious admissions were modest, holistic, individualised. The litigation showed that they were not. A conservative who believes in institutions does not celebrate this enforcement action; he regrets that it was necessary. The schools could have honoured the doctrine they were given. They preferred not to. The bill is now arriving.
What makes the UCLA case particularly significant is its setting. Medicine is a profession with restricted entry, public licensure, and a moral claim — it is supposed to be the field in which standards are not negotiable. If race-conscious admissions are illegal at the law schools and undergraduate colleges, they cannot be permitted at the medical schools that train the physicians who will set the standards for everyone else. That the Justice Department has acted at one of the country’s most prestigious medical programmes signals that the enforcement regime intends to be serious. The remedy will be unpleasant for UCLA. It will be salutary for the doctrine.
What to watch
Three signals over the coming year. First, the precise remedy: a consent decree with structural reform, a financial penalty, or a withdrawal of federal funding. The DOJ’s choice will signal how aggressive the enforcement regime intends to be at peer institutions. Second, the response of the American Association of Medical Colleges, which has been the institutional defender of race-conscious approaches in medical education; its compliance posture will set the national tone. Third, the pipeline effect: whether downstream programmes — residency matching, fellowship selection, attending appointments — adjust their own practices in anticipation of further enforcement, or wait to be told.
— J